Normal platelet reactivity in apolipoprotein E (apo E)-deficient mouse

Author： Nofer Jerzy-Roch Brodde Martin Herminghaus GraÅ¼yna Seedorf Udo Assmann Gerd Kehrel Beate E.

ISSN： 1369-1635

Source： Platelets, Vol.17, Iss.7, 2006-11, pp. : 498-500

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation

By Calkin A. Giunti S. Sheehy K. Chew C. Boolell V. Rajaram Y. Cooper M. Jandeleit-Dahm K.

Diabetologia, Vol. 51, Iss. 9, 2008-09 ,pp. : 1731-1740

Springer Publishing Company

Access to resources Recommend Favorite

BubR1 Insufficiency Results in Decreased Macrophage Proliferation and Attenuated Atherogenesis in Apolipoprotein E‐Deficient Mice

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 9, 2016-09 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Astrogliosis and the ApoE Genotype

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 4, 1999-06 ,pp. : 252-257

Karger

Access to resources Recommend Favorite

Inhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion

By Riddell D.R. Owen J.S.

Thrombosis Research, Vol. 81, Iss. 5, 1996-03 ,pp. : 597-606

Elsevier

Access to resources Recommend Favorite

Inhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion

By Riddell D.R. Owen J.S.

Thrombosis Research, Vol. 80, Iss. 6, 1995-12 ,pp. : 499-508

Elsevier

Access to resources Recommend Favorite